Summary of Product Characteristics
last updated on the eMC:
08/06/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 08/06/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
-
Change to section 4.2 - Posology and method of administration
-
Change to section 4.3 - Contraindications
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 5.1 - Pharmacodynamic Properties
-
Change to section 6. 6 - Instructions for use, handling and disposal
|
| Date of revision of text on the SPC: 06-Jun-2011 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| To update Sections 4.1, 4.2, 4.3 and 4.6 of the SPC relating to harm reduction and NRT. This follows advice from the CHM and MHRA. In addition, updates have been made to Section 5.1 (advice on weight gain) and 6.6 (safe disposal).
|
|
Updated on 23/07/2010 and displayed until 08/06/2011
|
Reasons for adding or updating:
|
|
|
| Date of revision of text on the SPC: |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
